Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News GSK American Depositary Shares Representing 2 Ordinary Shares GSK

Consumer Cyclical

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with... see more

Add To Watchlist

Recent & Breaking News (NYSE:GSK)

Tivicay® (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV

PR Newswire November 22, 2013

Isis Earns $5 Million in Milestone Payment from GSK for Advancement of ISIS-GSK4 Rx

PR Newswire November 15, 2013

BREO® ELLIPTA(TM) now available in the U.S. for the treatment of COPD

PR Newswire October 30, 2013

BREO(R) ELLIPTA(TM) Now Available in the U.S. for the Treatment of COPD

Marketwired October 30, 2013

ViiV Healthcare announces European regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV

PR Newswire October 25, 2013

Large cap results digest: Boeing up, Encana up, CP Rail record

Canadian Press October 23, 2013

ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV

PR Newswire October 22, 2013

Hagens Berman: U.S. Judge Rejects Pharmaceutical Companies' Attempt to Dismiss Thalidomide Cases

Business Wire September 27, 2013

Ligand Partner GSK Receives Marketing Authorization from the European Commission for Additional Revolade(TM) (Eltrombopag) Indication as the First Approved Treatment for Chronic Hepatitis C-Associated Thrombocytopenia

Business Wire September 24, 2013

RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma

Marketwired September 20, 2013

RELVAR(TM) ELLIPTA(TM) Receives Positive Opinion From the CHMP in Europe for the Treatment of Asthma and COPD

Marketwired September 19, 2013

Technical Scrutiny: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca PLC, and Raptor Pharma Corp.

PR Newswire September 19, 2013

Health Departments and Individuals Honored with NC GlaxoSmithKline Foundation 2013 Child Health Awards

PR Newswire September 18, 2013

GlaxoSmithKline, Community Care of North Carolina harness "small data" to improve patient care and reduce health care costs

PR Newswire September 18, 2013

ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1

PR Newswire September 12, 2013

GSK research estimates significantly higher rates of pertussis among older adults than now reported

PR Newswire September 12, 2013

FDA Advisory Committee Recommends Approval in US of Umeclidinium/Vilanterol for the Treatment of COPD

Marketwired September 10, 2013

ViiV Healthcare Expands HIV/AIDS Community Support in Hard-Hit Southern U.S.

PR Newswire September 4, 2013

RDInvesting Provides Investors with Free In-Depth Equity Reports on GRMN, GSK, QCOR and UBNT

Accesswire August 22, 2013

Additional GlaxoSmithKline quadrivalent intramuscular influenza vaccine approved by FDA

PR Newswire August 16, 2013